Search

Alpesh Shah

Examiner (ID: 405)

Most Active Art Unit
2302
Art Unit(s)
2756, 2302, 2783, 2315
Total Applications
455
Issued Applications
326
Pending Applications
23
Abandoned Applications
106

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1137638 [patent_doc_number] => 06780609 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-24 [patent_title] => 'High bone mass gene of 1.1q13.3' [patent_app_type] => B1 [patent_app_number] => 09/543771 [patent_app_country] => US [patent_app_date] => 2000-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 36 [patent_no_of_words] => 97277 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780609.pdf [firstpage_image] =>[orig_patent_app_number] => 09543771 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/543771
High bone mass gene of 1.1q13.3 Apr 4, 2000 Issued
Array ( [id] => 6414440 [patent_doc_number] => 20020038465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Non-human animal mutants and methods for production of the same' [patent_app_type] => new [patent_app_number] => 09/539526 [patent_app_country] => US [patent_app_date] => 2000-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2857 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20020038465.pdf [firstpage_image] =>[orig_patent_app_number] => 09539526 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/539526
Non-human animal mutants and methods for production of the same Mar 29, 2000 Abandoned
Array ( [id] => 1377248 [patent_doc_number] => 06563016 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses' [patent_app_type] => B1 [patent_app_number] => 09/536231 [patent_app_country] => US [patent_app_date] => 2000-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 25545 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/563/06563016.pdf [firstpage_image] =>[orig_patent_app_number] => 09536231 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/536231
Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses Mar 26, 2000 Issued
Array ( [id] => 4383769 [patent_doc_number] => 06303845 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'HS-40 enhancer-containing vector' [patent_app_type] => 1 [patent_app_number] => 9/536094 [patent_app_country] => US [patent_app_date] => 2000-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4022 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303845.pdf [firstpage_image] =>[orig_patent_app_number] => 536094 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/536094
HS-40 enhancer-containing vector Mar 23, 2000 Issued
09/516493 Novel glucose transporter/sensor protein and uses thereof Feb 29, 2000 Abandoned
09/514066 Formulations and methods for using the same to elicit and immune response Feb 24, 2000 Abandoned
Array ( [id] => 1240778 [patent_doc_number] => 06682745 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-27 [patent_title] => 'Use of bacterium for manufacture of a vaccine' [patent_app_type] => B1 [patent_app_number] => 09/492206 [patent_app_country] => US [patent_app_date] => 2000-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2858 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/682/06682745.pdf [firstpage_image] =>[orig_patent_app_number] => 09492206 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/492206
Use of bacterium for manufacture of a vaccine Jan 26, 2000 Issued
Array ( [id] => 1082779 [patent_doc_number] => 06833252 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-21 [patent_title] => 'Nucleotide sequence encoding the enzyme I-SecI and the uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/492697 [patent_app_country] => US [patent_app_date] => 2000-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 64 [patent_no_of_words] => 24211 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/833/06833252.pdf [firstpage_image] =>[orig_patent_app_number] => 09492697 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/492697
Nucleotide sequence encoding the enzyme I-SecI and the uses thereof Jan 26, 2000 Issued
Array ( [id] => 1336229 [patent_doc_number] => 06589505 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-08 [patent_title] => 'Cells that lack p19ink4d and p27kip1 activity and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/483597 [patent_app_country] => US [patent_app_date] => 2000-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 30 [patent_no_of_words] => 20052 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/589/06589505.pdf [firstpage_image] =>[orig_patent_app_number] => 09483597 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/483597
Cells that lack p19ink4d and p27kip1 activity and methods of use thereof Jan 13, 2000 Issued
Array ( [id] => 1439341 [patent_doc_number] => 06495131 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Interleukin-3 gene therapy for cancer' [patent_app_type] => B1 [patent_app_number] => 09/481201 [patent_app_country] => US [patent_app_date] => 2000-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15936 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495131.pdf [firstpage_image] =>[orig_patent_app_number] => 09481201 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/481201
Interleukin-3 gene therapy for cancer Jan 10, 2000 Issued
Array ( [id] => 582066 [patent_doc_number] => 07445890 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-11-04 [patent_title] => 'Ucp-2 promoter and use thereof' [patent_app_type] => utility [patent_app_number] => 09/869098 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7115 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/445/07445890.pdf [firstpage_image] =>[orig_patent_app_number] => 09869098 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/869098
Ucp-2 promoter and use thereof Dec 21, 1999 Issued
Array ( [id] => 668326 [patent_doc_number] => 07094565 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-22 [patent_title] => '21612, novel human dehydrogenases' [patent_app_type] => utility [patent_app_number] => 09/464039 [patent_app_country] => US [patent_app_date] => 1999-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 22 [patent_no_of_words] => 33961 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094565.pdf [firstpage_image] =>[orig_patent_app_number] => 09464039 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/464039
21612, novel human dehydrogenases Dec 14, 1999 Issued
Array ( [id] => 1415264 [patent_doc_number] => 06506378 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Vesicular monoamine transporter gene therapy in Parkinson\'s disease' [patent_app_type] => B1 [patent_app_number] => 09/461793 [patent_app_country] => US [patent_app_date] => 1999-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 24 [patent_no_of_words] => 26527 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506378.pdf [firstpage_image] =>[orig_patent_app_number] => 09461793 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/461793
Vesicular monoamine transporter gene therapy in Parkinson's disease Dec 14, 1999 Issued
09/456357 VIRAL VECTORS ENCODING APOPTOSIS-INDUCING PROTEINS AND METHODS FOR MAKING AND USING THE SAME Dec 7, 1999 Abandoned
Array ( [id] => 1587451 [patent_doc_number] => 06482403 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Caniney IL-13 immunoregulatory proteins and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/451527 [patent_app_country] => US [patent_app_date] => 1999-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80840 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482403.pdf [firstpage_image] =>[orig_patent_app_number] => 09451527 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/451527
Caniney IL-13 immunoregulatory proteins and uses thereof Nov 30, 1999 Issued
09/452140 INTERLEUKIN-1 HOMOLOGUE, MAT IL-1H4 Nov 30, 1999 Abandoned
Array ( [id] => 6769482 [patent_doc_number] => 20030215422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'AAV4 VECTOR AND USES THEREOF' [patent_app_type] => new [patent_app_number] => 09/254747 [patent_app_country] => US [patent_app_date] => 1999-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15198 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215422.pdf [firstpage_image] =>[orig_patent_app_number] => 09254747 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/254747
AAV4 VECTOR AND USES THEREOF Nov 25, 1999 Abandoned
Array ( [id] => 1387350 [patent_doc_number] => 06540995 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Encapsulated cells producing cytochrome P450' [patent_app_type] => B1 [patent_app_number] => 09/442979 [patent_app_country] => US [patent_app_date] => 1999-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11909 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/540/06540995.pdf [firstpage_image] =>[orig_patent_app_number] => 09442979 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/442979
Encapsulated cells producing cytochrome P450 Nov 17, 1999 Issued
Array ( [id] => 1358438 [patent_doc_number] => 06576813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-10 [patent_title] => 'Knockout animals' [patent_app_type] => B2 [patent_app_number] => 09/355405 [patent_app_country] => US [patent_app_date] => 1999-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6244 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576813.pdf [firstpage_image] =>[orig_patent_app_number] => 09355405 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/355405
Knockout animals Nov 17, 1999 Issued
Array ( [id] => 798015 [patent_doc_number] => 07427602 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-09-23 [patent_title] => 'Sustained DNA delivery from structural matrices' [patent_app_type] => utility [patent_app_number] => 09/442542 [patent_app_country] => US [patent_app_date] => 1999-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 43970 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/427/07427602.pdf [firstpage_image] =>[orig_patent_app_number] => 09442542 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/442542
Sustained DNA delivery from structural matrices Nov 17, 1999 Issued
Menu